PubMed · 6156026
Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
Abstract
Rats with the solid Walker carcinosarcoma 256 were synchronized with hydroxyurea (6 x 50 mg/kg or 1 x 300 mg/kg body weight) and treated with bleomycin (32 mg/kg body weight) at different time points thereafter. Bleomycin clearly affects Walker carcinosarcoma cells at the G1/S boundary or in S-phase. The improvement in the results of bleomycin therapy after pretreatment with hydroxyurea can mainly be accounted for by the synchronization of the tumour cells.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Volm, J Mattern, N Weber, K Wayss. 1980. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.. https://doi.org/10.1007/bf00254028
Cite the original work for its findings. Save a collection to share your selection of sources.